Edward Lau
Concepts (367)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 33 | 2026 | 1188 | 5.460 |
Why?
| | Proteome | 21 | 2025 | 514 | 5.350 |
Why?
| | Myocardium | 14 | 2026 | 934 | 2.200 |
Why?
| | Induced Pluripotent Stem Cells | 9 | 2025 | 273 | 2.010 |
Why?
| | Deuterium Oxide | 5 | 2026 | 20 | 1.970 |
Why?
| | Proteins | 8 | 2026 | 1023 | 1.860 |
Why?
| | Cell Culture Techniques | 2 | 2026 | 372 | 1.520 |
Why?
| | Mitochondrial Proteins | 7 | 2015 | 263 | 1.360 |
Why?
| | Computational Biology | 6 | 2025 | 669 | 1.340 |
Why?
| | Myocytes, Cardiac | 8 | 2025 | 546 | 1.310 |
Why?
| | Transcriptome | 6 | 2025 | 1038 | 1.270 |
Why?
| | Mass Spectrometry | 11 | 2026 | 730 | 1.110 |
Why?
| | Gene Expression Profiling | 5 | 2025 | 1767 | 1.100 |
Why?
| | Deuterium | 2 | 2025 | 100 | 1.070 |
Why?
| | Isotope Labeling | 3 | 2025 | 82 | 1.040 |
Why?
| | Alternative Splicing | 6 | 2025 | 247 | 0.950 |
Why?
| | Mitochondria, Heart | 7 | 2016 | 107 | 0.820 |
Why?
| | Proteostasis | 1 | 2024 | 27 | 0.810 |
Why?
| | Cardiology | 2 | 2018 | 362 | 0.810 |
Why?
| | Muscle Proteins | 5 | 2025 | 242 | 0.800 |
Why?
| | Cell Differentiation | 5 | 2025 | 2046 | 0.730 |
Why?
| | Lysine | 2 | 2022 | 305 | 0.690 |
Why?
| | Muscle, Striated | 1 | 2021 | 12 | 0.690 |
Why?
| | Mitochondria | 6 | 2020 | 992 | 0.690 |
Why?
| | Protein Isoforms | 5 | 2025 | 397 | 0.660 |
Why?
| | Cardiomegaly | 2 | 2018 | 174 | 0.590 |
Why?
| | Animals | 37 | 2026 | 38030 | 0.550 |
Why?
| | Hemodynamics | 1 | 2023 | 1118 | 0.550 |
Why?
| | Semantics | 1 | 2018 | 96 | 0.540 |
Why?
| | Bibliometrics | 1 | 2018 | 66 | 0.540 |
Why?
| | Systems Biology | 1 | 2018 | 69 | 0.540 |
Why?
| | Disease | 1 | 2018 | 96 | 0.530 |
Why?
| | Aging | 4 | 2023 | 1969 | 0.530 |
Why?
| | Blood Proteins | 4 | 2025 | 239 | 0.510 |
Why?
| | Proteolysis | 4 | 2025 | 172 | 0.490 |
Why?
| | Gene Regulatory Networks | 3 | 2025 | 317 | 0.420 |
Why?
| | Chromatography, Liquid | 4 | 2013 | 450 | 0.400 |
Why?
| | Precision Medicine | 1 | 2018 | 459 | 0.400 |
Why?
| | Mice | 21 | 2025 | 18329 | 0.390 |
Why?
| | Noise | 1 | 2012 | 72 | 0.360 |
Why?
| | Oxidative Stress | 3 | 2020 | 1356 | 0.340 |
Why?
| | Data Mining | 3 | 2018 | 113 | 0.340 |
Why?
| | Peptide Hydrolases | 1 | 2012 | 105 | 0.340 |
Why?
| | Humans | 44 | 2026 | 145474 | 0.330 |
Why?
| | Chromatography, Ion Exchange | 1 | 2011 | 57 | 0.330 |
Why?
| | Amino Acids | 2 | 2026 | 519 | 0.310 |
Why?
| | Pluripotent Stem Cells | 2 | 2021 | 82 | 0.290 |
Why?
| | Half-Life | 2 | 2026 | 155 | 0.250 |
Why?
| | Chromatography, Reverse-Phase | 3 | 2011 | 27 | 0.250 |
Why?
| | Heart | 2 | 2025 | 626 | 0.250 |
Why?
| | Protein Corona | 1 | 2026 | 9 | 0.250 |
Why?
| | Tandem Mass Spectrometry | 6 | 2021 | 572 | 0.240 |
Why?
| | Peptides | 4 | 2025 | 998 | 0.240 |
Why?
| | Cell Compartmentation | 1 | 2025 | 52 | 0.230 |
Why?
| | Unfolded Protein Response | 2 | 2024 | 58 | 0.230 |
Why?
| | Cell Line | 7 | 2021 | 2823 | 0.230 |
Why?
| | Galectin 3 | 1 | 2025 | 21 | 0.230 |
Why?
| | Kinetics | 3 | 2025 | 1567 | 0.230 |
Why?
| | Galectins | 1 | 2025 | 26 | 0.230 |
Why?
| | Joint Diseases | 1 | 2025 | 65 | 0.220 |
Why?
| | MicroRNAs | 2 | 2022 | 686 | 0.220 |
Why?
| | RNA, Messenger | 3 | 2022 | 2803 | 0.210 |
Why?
| | Gene Expression Regulation | 4 | 2022 | 2597 | 0.200 |
Why?
| | Golgi Apparatus | 1 | 2024 | 99 | 0.200 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2024 | 42 | 0.200 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1789 | 0.200 |
Why?
| | Biomarkers | 6 | 2026 | 4295 | 0.190 |
Why?
| | Osteoarthritis | 1 | 2025 | 200 | 0.190 |
Why?
| | Heart Diseases | 1 | 2026 | 341 | 0.190 |
Why?
| | Proteogenomics | 1 | 2022 | 12 | 0.180 |
Why?
| | Signal Transduction | 3 | 2025 | 5216 | 0.180 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2014 | 155 | 0.180 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2013 | 117 | 0.180 |
Why?
| | Organoids | 1 | 2024 | 145 | 0.180 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2012 | 92 | 0.170 |
Why?
| | Water | 1 | 2025 | 445 | 0.170 |
Why?
| | Dementia | 1 | 2025 | 327 | 0.170 |
Why?
| | Fibroblasts | 2 | 2025 | 1025 | 0.160 |
Why?
| | Refugium | 1 | 2020 | 4 | 0.160 |
Why?
| | Paraquat | 1 | 2020 | 13 | 0.160 |
Why?
| | Chloroplasts | 2 | 2011 | 17 | 0.160 |
Why?
| | Electroencephalography | 2 | 2016 | 561 | 0.160 |
Why?
| | Databases, Nucleic Acid | 1 | 2020 | 38 | 0.160 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 78 | 0.160 |
Why?
| | Calcium | 3 | 2021 | 1190 | 0.160 |
Why?
| | Iron Overload | 1 | 2020 | 19 | 0.160 |
Why?
| | Robotics | 1 | 2021 | 90 | 0.160 |
Why?
| | Embryonic Stem Cells | 1 | 2021 | 124 | 0.160 |
Why?
| | Phosphorylation | 3 | 2021 | 1707 | 0.160 |
Why?
| | Nanoparticles | 1 | 2026 | 517 | 0.160 |
Why?
| | Hallucinogens | 1 | 2022 | 111 | 0.150 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 221 | 0.150 |
Why?
| | Cells, Cultured | 2 | 2025 | 4148 | 0.150 |
Why?
| | Cardiomyopathy, Dilated | 2 | 2021 | 356 | 0.150 |
Why?
| | Arabidopsis Proteins | 2 | 2011 | 76 | 0.150 |
Why?
| | Software | 1 | 2025 | 680 | 0.150 |
Why?
| | Heart Failure | 3 | 2022 | 2326 | 0.150 |
Why?
| | Exosomes | 1 | 2020 | 104 | 0.150 |
Why?
| | Aquatic Organisms | 2 | 2020 | 9 | 0.150 |
Why?
| | Cryopreservation | 1 | 2020 | 113 | 0.150 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 31 | 0.150 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 85 | 0.150 |
Why?
| | Lamin Type A | 1 | 2019 | 49 | 0.150 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2129 | 0.150 |
Why?
| | Endothelial Cells | 2 | 2022 | 874 | 0.140 |
Why?
| | Mutation | 3 | 2019 | 4075 | 0.140 |
Why?
| | Codon, Nonsense | 1 | 2019 | 44 | 0.140 |
Why?
| | Doxorubicin | 1 | 2021 | 401 | 0.140 |
Why?
| | Liver | 2 | 2025 | 1896 | 0.140 |
Why?
| | Fatty Acids | 1 | 2022 | 457 | 0.140 |
Why?
| | Databases, Factual | 2 | 2016 | 1490 | 0.140 |
Why?
| | High-Throughput Screening Assays | 1 | 2020 | 176 | 0.140 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 105 | 0.140 |
Why?
| | Atrial Remodeling | 1 | 2018 | 10 | 0.140 |
Why?
| | Glycoproteins | 2 | 2010 | 354 | 0.130 |
Why?
| | Genotyping Techniques | 1 | 2018 | 71 | 0.130 |
Why?
| | Models, Biological | 3 | 2020 | 1764 | 0.130 |
Why?
| | Species Specificity | 2 | 2016 | 546 | 0.130 |
Why?
| | Mice, Inbred DBA | 1 | 2018 | 182 | 0.130 |
Why?
| | Biodiversity | 1 | 2020 | 311 | 0.130 |
Why?
| | Body Mass Index | 1 | 2026 | 2445 | 0.130 |
Why?
| | Causality | 1 | 2018 | 126 | 0.130 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2019 | 143 | 0.130 |
Why?
| | Mice, Inbred Strains | 1 | 2018 | 396 | 0.130 |
Why?
| | Smartphone | 1 | 2018 | 106 | 0.130 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2883 | 0.120 |
Why?
| | Knowledge Management | 1 | 2016 | 2 | 0.120 |
Why?
| | Databases, Bibliographic | 1 | 2016 | 30 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2020 | 335 | 0.120 |
Why?
| | Knowledge Bases | 1 | 2016 | 28 | 0.120 |
Why?
| | Alpha Rhythm | 1 | 2016 | 11 | 0.120 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 288 | 0.120 |
Why?
| | Environmental Monitoring | 1 | 2018 | 346 | 0.110 |
Why?
| | Ventricular Remodeling | 1 | 2018 | 278 | 0.110 |
Why?
| | Homeostasis | 3 | 2019 | 642 | 0.110 |
Why?
| | Mobile Applications | 1 | 2018 | 199 | 0.110 |
Why?
| | Genomics | 1 | 2020 | 825 | 0.110 |
Why?
| | Hepatocytes | 2 | 2013 | 224 | 0.110 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1261 | 0.110 |
Why?
| | Cannabis | 1 | 2022 | 509 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 118 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2019 | 728 | 0.110 |
Why?
| | Ecosystem | 2 | 2020 | 478 | 0.110 |
Why?
| | Male | 13 | 2025 | 72842 | 0.100 |
Why?
| | Mammals | 1 | 2016 | 286 | 0.100 |
Why?
| | Glycopeptides | 2 | 2011 | 44 | 0.100 |
Why?
| | Information Dissemination | 1 | 2016 | 224 | 0.100 |
Why?
| | Ubiquitination | 1 | 2014 | 118 | 0.100 |
Why?
| | RNA | 1 | 2020 | 910 | 0.100 |
Why?
| | Isoproterenol | 1 | 2014 | 96 | 0.100 |
Why?
| | DNA | 1 | 2020 | 1435 | 0.100 |
Why?
| | Cyclophilins | 1 | 2013 | 40 | 0.100 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5983 | 0.100 |
Why?
| | Cardiovascular Diseases | 3 | 2022 | 2187 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2018 | 578 | 0.100 |
Why?
| | Heart Ventricles | 3 | 2024 | 756 | 0.100 |
Why?
| | Chondrocytes | 1 | 2015 | 232 | 0.100 |
Why?
| | Phenotype | 2 | 2020 | 3155 | 0.100 |
Why?
| | Memory, Short-Term | 1 | 2016 | 268 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2021 | 2028 | 0.100 |
Why?
| | Conservation of Natural Resources | 1 | 2014 | 119 | 0.090 |
Why?
| | Pseudoxanthoma Elasticum | 1 | 2012 | 1 | 0.090 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2012 | 19 | 0.090 |
Why?
| | Monte Carlo Method | 1 | 2012 | 147 | 0.090 |
Why?
| | Mitochondrial Membranes | 1 | 2012 | 40 | 0.090 |
Why?
| | Cerebral Cortex | 1 | 2016 | 473 | 0.090 |
Why?
| | Mitochondria, Liver | 1 | 2012 | 70 | 0.090 |
Why?
| | Cytoprotection | 1 | 2012 | 56 | 0.090 |
Why?
| | Enzyme Stability | 1 | 2012 | 73 | 0.090 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 110 | 0.090 |
Why?
| | Research | 1 | 2015 | 430 | 0.090 |
Why?
| | Glycomics | 1 | 2011 | 7 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 717 | 0.090 |
Why?
| | Oxidants | 1 | 2012 | 99 | 0.090 |
Why?
| | Graphite | 1 | 2011 | 14 | 0.090 |
Why?
| | Temperature | 1 | 2014 | 633 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 429 | 0.090 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1407 | 0.080 |
Why?
| | Isoenzymes | 1 | 2012 | 294 | 0.080 |
Why?
| | Substrate Specificity | 1 | 2012 | 387 | 0.080 |
Why?
| | Peptide Mapping | 1 | 2011 | 62 | 0.080 |
Why?
| | Water Pollutants, Chemical | 1 | 2014 | 227 | 0.080 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 343 | 0.080 |
Why?
| | Cations | 1 | 2011 | 83 | 0.080 |
Why?
| | Hippocampus | 1 | 2016 | 971 | 0.080 |
Why?
| | Calcinosis | 1 | 2012 | 234 | 0.080 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 335 | 0.080 |
Why?
| | Female | 10 | 2026 | 78844 | 0.080 |
Why?
| | Oryza | 1 | 2010 | 32 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2016 | 935 | 0.080 |
Why?
| | Alzheimer Disease | 1 | 2016 | 630 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2010 | 244 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 387 | 0.070 |
Why?
| | Plant Proteins | 1 | 2010 | 111 | 0.070 |
Why?
| | Nitric Oxide Synthase | 1 | 2010 | 234 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 452 | 0.070 |
Why?
| | Cell Membrane | 1 | 2013 | 707 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 174 | 0.070 |
Why?
| | Arabidopsis | 1 | 2010 | 93 | 0.070 |
Why?
| | Haploinsufficiency | 2 | 2019 | 54 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3413 | 0.070 |
Why?
| | Stroke Volume | 2 | 2022 | 654 | 0.070 |
Why?
| | Epilepsy | 1 | 2012 | 390 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 592 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 2378 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2588 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2011 | 693 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 355 | 0.060 |
Why?
| | Polystyrenes | 1 | 2026 | 38 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3904 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2026 | 119 | 0.060 |
Why?
| | Polysaccharides | 3 | 2011 | 86 | 0.060 |
Why?
| | Principal Component Analysis | 1 | 2026 | 193 | 0.060 |
Why?
| | Sarcomeres | 1 | 2025 | 97 | 0.060 |
Why?
| | Equipment Design | 3 | 2011 | 525 | 0.050 |
Why?
| | United Kingdom | 1 | 2025 | 344 | 0.050 |
Why?
| | Algorithms | 1 | 2012 | 1845 | 0.050 |
Why?
| | Calcium Signaling | 2 | 2019 | 245 | 0.050 |
Why?
| | Tensins | 1 | 2024 | 5 | 0.050 |
Why?
| | LIM Domain Proteins | 1 | 2024 | 20 | 0.050 |
Why?
| | Organ Specificity | 1 | 2024 | 309 | 0.050 |
Why?
| | Heart Atria | 1 | 2024 | 141 | 0.050 |
Why?
| | Rats | 2 | 2022 | 5584 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 13 | 0.050 |
Why?
| | Genistein | 1 | 2022 | 13 | 0.050 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2022 | 44 | 0.050 |
Why?
| | Cats | 1 | 2022 | 231 | 0.040 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 39 | 0.040 |
Why?
| | Protein Transport | 2 | 2015 | 442 | 0.040 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 32 | 0.040 |
Why?
| | Automation | 1 | 2021 | 104 | 0.040 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 24 | 0.040 |
Why?
| | Cardiotoxicity | 1 | 2021 | 35 | 0.040 |
Why?
| | Cyclic N-Oxides | 1 | 2020 | 32 | 0.040 |
Why?
| | Hong Kong | 1 | 2020 | 7 | 0.040 |
Why?
| | Fluorometry | 1 | 2020 | 19 | 0.040 |
Why?
| | Laboratories | 1 | 2021 | 110 | 0.040 |
Why?
| | Azoles | 1 | 2020 | 4 | 0.040 |
Why?
| | Isoindoles | 1 | 2020 | 5 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 192 | 0.040 |
Why?
| | Spin Labels | 1 | 2020 | 59 | 0.040 |
Why?
| | RNA Splicing | 1 | 2022 | 284 | 0.040 |
Why?
| | Organoselenium Compounds | 1 | 2020 | 10 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2025 | 910 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 369 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2020 | 59 | 0.040 |
Why?
| | Analgesics | 1 | 2022 | 231 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 182 | 0.040 |
Why?
| | Teratoma | 1 | 2021 | 124 | 0.040 |
Why?
| | Organophosphorus Compounds | 1 | 2020 | 84 | 0.040 |
Why?
| | Cell Death | 1 | 2021 | 382 | 0.040 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2019 | 19 | 0.040 |
Why?
| | Dronabinol | 1 | 2022 | 249 | 0.040 |
Why?
| | Piperidines | 1 | 2020 | 222 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 542 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2020 | 293 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 741 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2019 | 108 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2022 | 447 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 611 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 442 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2026 | 1581 | 0.030 |
Why?
| | Linear Models | 1 | 2020 | 845 | 0.030 |
Why?
| | Gene Editing | 1 | 2019 | 89 | 0.030 |
Why?
| | Protein Binding | 1 | 2024 | 2238 | 0.030 |
Why?
| | Iron | 1 | 2020 | 357 | 0.030 |
Why?
| | Cattle | 2 | 2010 | 946 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1048 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2170 | 0.030 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2016 | 5 | 0.030 |
Why?
| | Mental Status Schedule | 1 | 2016 | 35 | 0.030 |
Why?
| | Clusterin | 1 | 2016 | 12 | 0.030 |
Why?
| | Prodromal Symptoms | 1 | 2016 | 20 | 0.030 |
Why?
| | Spatial Learning | 1 | 2016 | 4 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2016 | 93 | 0.030 |
Why?
| | Brain Chemistry | 1 | 2016 | 119 | 0.030 |
Why?
| | Risk Factors | 2 | 2025 | 10885 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 362 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1476 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2524 | 0.030 |
Why?
| | Hypertrophy | 1 | 2015 | 128 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 461 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 553 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 587 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2016 | 138 | 0.030 |
Why?
| | Multifactorial Inheritance | 1 | 2016 | 195 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 174 | 0.030 |
Why?
| | Seawater | 1 | 2014 | 33 | 0.030 |
Why?
| | Extracellular Matrix Proteins | 1 | 2015 | 156 | 0.030 |
Why?
| | Water Quality | 1 | 2014 | 35 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 113 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2016 | 531 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 2014 | 92 | 0.020 |
Why?
| | Acetylation | 1 | 2014 | 259 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2021 | 2507 | 0.020 |
Why?
| | Pregnancy | 1 | 2026 | 7202 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 331 | 0.020 |
Why?
| | Intestines | 1 | 2016 | 354 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 8057 | 0.020 |
Why?
| | Middle Aged | 3 | 2025 | 36215 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2016 | 1300 | 0.020 |
Why?
| | American Recovery and Reinvestment Act | 1 | 2012 | 6 | 0.020 |
Why?
| | Obesity | 1 | 2026 | 3116 | 0.020 |
Why?
| | Mandatory Programs | 1 | 2012 | 16 | 0.020 |
Why?
| | Nerve Net | 1 | 2016 | 284 | 0.020 |
Why?
| | Genes, Mitochondrial | 1 | 2012 | 13 | 0.020 |
Why?
| | Cell Fractionation | 1 | 2012 | 50 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1547 | 0.020 |
Why?
| | Biotinylation | 1 | 2012 | 37 | 0.020 |
Why?
| | Cell Survival | 1 | 2015 | 1100 | 0.020 |
Why?
| | Database Management Systems | 1 | 2012 | 51 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2440 | 0.020 |
Why?
| | Cell Respiration | 1 | 2012 | 105 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2012 | 254 | 0.020 |
Why?
| | Climate Change | 1 | 2014 | 177 | 0.020 |
Why?
| | Transcription Factors | 1 | 2020 | 1734 | 0.020 |
Why?
| | Carbohydrate Conformation | 1 | 2011 | 15 | 0.020 |
Why?
| | Concanavalin A | 1 | 2011 | 72 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2012 | 147 | 0.020 |
Why?
| | Adult | 3 | 2026 | 40777 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2022 | 4560 | 0.020 |
Why?
| | Drosophila melanogaster | 1 | 2013 | 237 | 0.020 |
Why?
| | Automation, Laboratory | 1 | 2011 | 8 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 779 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1134 | 0.020 |
Why?
| | Protein Conformation | 1 | 2014 | 938 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2016 | 1061 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2864 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 428 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 978 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2878 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2011 | 171 | 0.020 |
Why?
| | Suppression, Genetic | 1 | 2010 | 25 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2188 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2010 | 72 | 0.020 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 26 | 0.020 |
Why?
| | Serum | 1 | 2010 | 58 | 0.020 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2010 | 54 | 0.020 |
Why?
| | Ribonucleases | 1 | 2010 | 48 | 0.020 |
Why?
| | Trypsin | 1 | 2010 | 75 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2010 | 93 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2011 | 531 | 0.020 |
Why?
| | Solvents | 1 | 2010 | 112 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 362 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7123 | 0.020 |
Why?
| | Models, Molecular | 1 | 2014 | 1598 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2016 | 1321 | 0.020 |
Why?
| | Serum Albumin | 1 | 2010 | 147 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2953 | 0.020 |
Why?
| | Kidney | 1 | 2016 | 1497 | 0.020 |
Why?
| | Decision Support Systems, Clinical | 1 | 2012 | 272 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 475 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 477 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 314 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 666 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 5423 | 0.020 |
Why?
| | Aged | 1 | 2025 | 26153 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2012 | 3124 | 0.010 |
Why?
| | Genotype | 1 | 2010 | 1852 | 0.010 |
Why?
| | Electronic Health Records | 1 | 2012 | 1196 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3542 | 0.010 |
Why?
| | Lung | 1 | 2016 | 4106 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14218 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 22529 | 0.010 |
Why?
| | Child | 1 | 2016 | 22707 | 0.010 |
Why?
| | United States | 1 | 2012 | 16098 | 0.010 |
Why?
|
|
Lau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|